BARCELONA, SPAIN – EVANIUM is proud to announce that its OPTISOLV® Berberine has been awarded the Most Innovative Nutraceutical Ingredient at the prestigious Vitafoods Europe Startup Challenge in Barcelona. This significant accolade underscores EVANIUM’s commitment to pioneering advancements in nutraceutical science and addressing critical challenges in ingredient bioavailability.
The esteemed jury at Vitafoods Europe 2026 recognized EVANIUM for its novel, IP-protected drug delivery technology, OPTISOLV®. This innovative platform significantly enhances the water solubility and taste profile of plant-derived ingredients, thereby broadening their application scope and enabling diverse dosage forms. Specifically, OPTISOLV® Berberine, a dual-coated Berberine formulation, demonstrates superior absorption and controlled release mechanisms, crucial for effective metabolic and blood sugar support.
EVANIUM’s proprietary dual-coating system is engineered to overcome the inherent bioavailability gap prevalent in many nutraceuticals. By increasing the solubility and absorption of active compounds, the technology empowers brands to develop impactful products that deliver tangible benefits to human health. OPTISOLV® Berberine represents one of four next-generation ingredients developed using this advanced technology, reflecting EVANIUM’s dedication to unlocking the full potential of ingredients.
“We are absolutely thrilled and incredibly proud of this recognition,” stated David Ofner, Co-Founder and CTO at EVANIUM. “This award is a testament to the relentless dedication and hard work of our entire team in Regensburg. We extend our deepest gratitude to the jury for acknowledging the innovation and transformative potential of our OPTISOLV® Technology. This achievement reinforces our collective commitment to driving innovation in nutraceuticals and functional foods.”
Read the full article at Vitafoods Insights here.
